| Code | Description | Claims | Beneficiaries | Total Paid |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
494 |
472 |
$63K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
672 |
639 |
$56K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
118 |
111 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
81 |
79 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
110 |
109 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
79 |
71 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
119 |
119 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
109 |
109 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
28 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
19 |
19 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
141 |
133 |
$3K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
28 |
28 |
$3K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
26 |
25 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
47 |
28 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
142 |
71 |
$1K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
18 |
15 |
$773.60 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15 |
15 |
$573.44 |
| 87070 |
|
23 |
20 |
$480.78 |